메뉴 건너뛰기




Volumn 127, Issue 12, 2016, Pages 1531-1538

PET-CT for staging and early response: Results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study

(23)  Barrington, Sally F a   Kirkwood, Amy A b   Franceschetto, Antonella c   Fulham, Michael J d,e   Roberts, Thomas H b   Almquist, Helén f   Brun, Eva f   Hjorthaug, Karin g   Viney, Zaid N h   Pike, Lucy C a   Federico, Massimo c   Luminari, Stefano c   Radford, John i   Trotman, Judith e,j   Fosså, Alexander k   Berkahn, Leanne l   Molin, Daniel m   D'Amore, Francesco n   Sinclair, Donald A a   Smith, Paul b   more..


Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

EID: 84962235427     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-11-679407     Document Type: Article
Times cited : (143)

References (44)
  • 1
    • 84860833364 scopus 로고    scopus 로고
    • Reducedintensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): A randomised, open-label, phase 3 non-inferiority trial
    • Engert A, Haverkamp H, Kobe C, et al; German Hodgkin Study Group; Swiss Group for Clinical Cancer Research; Arbeitsgemeinschaft Medikamentöse Tumortherapie. Reducedintensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet. 2012;379(9828):1791-1799.
    • (2012) Lancet , vol.379 , Issue.9828 , pp. 1791-1799
    • Engert, A.1    Haverkamp, H.2    Kobe, C.3
  • 2
    • 34548486030 scopus 로고    scopus 로고
    • Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: A report from a joint Italian-Danish study
    • Gallamini A, Hutchings M, Rigacci L, et al. Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. J Clin Oncol. 2007;25(24): 3746-3752.
    • (2007) J Clin Oncol , vol.25 , Issue.24 , pp. 3746-3752
    • Gallamini, A.1    Hutchings, M.2    Rigacci, L.3
  • 3
    • 33645963756 scopus 로고    scopus 로고
    • Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma
    • Hutchings M, Loft A, Hansen M, et al. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica. 2006;91(4):482-489.
    • (2006) Haematologica , vol.91 , Issue.4 , pp. 482-489
    • Hutchings, M.1    Loft, A.2    Hansen, M.3
  • 4
    • 30144432586 scopus 로고    scopus 로고
    • FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
    • Hutchings M, Loft A, Hansen M, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood. 2006;107(1):52-59.
    • (2006) Blood , vol.107 , Issue.1 , pp. 52-59
    • Hutchings, M.1    Loft, A.2    Hansen, M.3
  • 5
    • 25444437438 scopus 로고    scopus 로고
    • Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma
    • Hutchings M, Mikhaeel NG, Fields PA, Nunan T, Timothy AR. Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma. Ann Oncol. 2005;16(7): 1160-1168.
    • (2005) Ann Oncol , vol.16 , Issue.7 , pp. 1160-1168
    • Hutchings, M.1    Mikhaeel, N.G.2    Fields, P.A.3    Nunan, T.4    Timothy, A.R.5
  • 6
    • 84907202542 scopus 로고    scopus 로고
    • Role of imaging in the staging and response assessment of lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
    • Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32(27):3048-3058.
    • (2014) J Clin Oncol , vol.32 , Issue.27 , pp. 3048-3058
    • Barrington, S.F.1    Mikhaeel, N.G.2    Kostakoglu, L.3
  • 7
    • 84903462466 scopus 로고    scopus 로고
    • Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification
    • Cheson BD, Fisher RI, Barrington SF, et al; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/ Dutch Hemato-Oncology Group; Grupo Espanõl de Médula Ó sea; German High-Grade Lymphoma Study Group; German Hodgkin's Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059-3068.
    • (2014) J Clin Oncol , vol.32 , Issue.27 , pp. 3059-3068
    • Cheson, B.D.1    Fisher, R.I.2    Barrington, S.F.3
  • 8
    • 84907226303 scopus 로고    scopus 로고
    • Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management
    • Chalaye J, Luciani A, Enache C, et al. Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management. Leuk Lymphoma. 2014;55(12):2887-2892.
    • (2014) Leuk Lymphoma , vol.55 , Issue.12 , pp. 2887-2892
    • Chalaye, J.1    Luciani, A.2    Enache, C.3
  • 9
    • 84856140491 scopus 로고    scopus 로고
    • Diagnostic value of CT, PET and combined PET/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma
    • Pinilla I, Gómez-Léon N, Del Campo-Del Val L, et al. Diagnostic value of CT, PET and combined PET/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma. Q J Nucl Med Mol Imaging. 2011; 55(5):567-575.
    • (2011) Q J Nucl Med Mol Imaging , vol.55 , Issue.5 , pp. 567-575
    • Pinilla, I.1    Gómez-Léon, N.2    Del Campo-Del Val, L.3
  • 10
    • 40849147717 scopus 로고    scopus 로고
    • Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi
    • Rigacci L, Vitolo U, Nassi L, et al; Intergruppo Italiano Linfomi. Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi. Ann Hematol. 2007; 86(12):897-903.
    • (2007) Ann Hematol , vol.86 , Issue.12 , pp. 897-903
    • Rigacci, L.1    Vitolo, U.2    Nassi, L.3
  • 11
    • 0031593417 scopus 로고    scopus 로고
    • Wholebody 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease
    • Bangerter M, Moog F, Buchmann I, et al. Wholebody 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. Ann Oncol. 1998; 9(10):1117-1122.
    • (1998) Ann Oncol , vol.9 , Issue.10 , pp. 1117-1122
    • Bangerter, M.1    Moog, F.2    Buchmann, I.3
  • 12
    • 0035074636 scopus 로고    scopus 로고
    • Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease
    • Jerusalem G, Beguin Y, Fassotte MF, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica. 2001;86(3):266-273.
    • (2001) Haematologica , vol.86 , Issue.3 , pp. 266-273
    • Jerusalem, G.1    Beguin, Y.2    Fassotte, M.F.3
  • 13
    • 9444279658 scopus 로고    scopus 로고
    • Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease
    • Munker R, Glass J, Griffeth LK, et al. Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease. Ann Oncol. 2004;15(11):1699-1704.
    • (2004) Ann Oncol , vol.15 , Issue.11 , pp. 1699-1704
    • Munker, R.1    Glass, J.2    Griffeth, L.K.3
  • 14
    • 10744230082 scopus 로고    scopus 로고
    • Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma
    • Naumann R, Beuthien-Baumann B, Reiss A, et al. Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. Br J Cancer. 2004;90(3): 620-625.
    • (2004) Br J Cancer , vol.90 , Issue.3 , pp. 620-625
    • Naumann, R.1    Beuthien-Baumann, B.2    Reiss, A.3
  • 15
    • 0033763664 scopus 로고    scopus 로고
    • 2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: Influence on patient management in a single institution
    • Partridge S, Timothy A, O'Doherty MJ, Hain SF, Rankin S, Mikhaeel G. 2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution. Ann Oncol. 2000;11(10):1273-1279.
    • (2000) Ann Oncol , vol.11 , Issue.10 , pp. 1273-1279
    • Partridge, S.1    Timothy, A.2    O'Doherty, M.J.3    Hain, S.F.4    Rankin, S.5    Mikhaeel, G.6
  • 16
    • 0036938607 scopus 로고    scopus 로고
    • Wholebody positron emission tomography using 18Ffluorodeoxyglucose for initial staging of patients with Hodgkin's disease
    • Weihrauch MR, Re D, Bischoff S, et al. Wholebody positron emission tomography using 18Ffluorodeoxyglucose for initial staging of patients with Hodgkin's disease. Ann Hematol. 2002;81(1): 20-25.
    • (2002) Ann Hematol , vol.81 , Issue.1 , pp. 20-25
    • Weihrauch, M.R.1    Re, D.2    Bischoff, S.3
  • 17
    • 0035281784 scopus 로고    scopus 로고
    • 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial
    • Buchmann I, Reinhardt M, Elsner K, et al. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer. 2001;91(5):889-899.
    • (2001) Cancer , vol.91 , Issue.5 , pp. 889-899
    • Buchmann, I.1    Reinhardt, M.2    Elsner, K.3
  • 18
    • 53049088385 scopus 로고
    • Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma
    • Elstrom RL, Leonard JP, Coleman M, Brown RK. Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma. Ann Oncol. 2008-1773;19(10): 1770-1773.
    • (1773) Ann Oncol , vol.19 , Issue.10 , pp. 1770-1773
    • Elstrom, R.L.1    Leonard, J.P.2    Coleman, M.3    Brown, R.K.4
  • 19
    • 48349111946 scopus 로고    scopus 로고
    • Role of wholebody [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/ CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma
    • Pelosi E, Pregno P, Penna D, et al. Role of wholebody [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/ CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma. Radiol Med (Torino). 2008; 113(4):578-590.
    • (2008) Radiol Med (Torino) , vol.113 , Issue.4 , pp. 578-590
    • Pelosi, E.1    Pregno, P.2    Penna, D.3
  • 20
    • 29844457730 scopus 로고    scopus 로고
    • Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?
    • Raanani P, Shasha Y, Perry C, et al. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol. 2006;17(1):117-122.
    • (2006) Ann Oncol , vol.17 , Issue.1 , pp. 117-122
    • Raanani, P.1    Shasha, Y.2    Perry, C.3
  • 21
    • 0036124658 scopus 로고    scopus 로고
    • Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma
    • Wirth A, Seymour JF, Hicks RJ, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. Am J Med. 2002; 112(4):262-268.
    • (2002) Am J Med , vol.112 , Issue.4 , pp. 262-268
    • Wirth, A.1    Seymour, J.F.2    Hicks, R.J.3
  • 22
    • 79952114063 scopus 로고    scopus 로고
    • Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
    • Barrington SF, Qian W, Somer EJ, et al. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging. 2010;37(10):1824-1833.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , Issue.10 , pp. 1824-1833
    • Barrington, S.F.1    Qian, W.2    Somer, E.J.3
  • 23
    • 84877115529 scopus 로고    scopus 로고
    • International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: Interpretation criteria and concordance rate among reviewers
    • Biggi A, Gallamini A, Chauvie S, et al. International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nucl Med. 2013;54(5):683-690.
    • (2013) J Nucl Med , vol.54 , Issue.5 , pp. 683-690
    • Biggi, A.1    Gallamini, A.2    Chauvie, S.3
  • 24
    • 79955504718 scopus 로고    scopus 로고
    • Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma-results for dedicated assessment criteria in a blinded dual-centre read
    • Furth C, Amthauer H, Hautzel H, et al. Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma-results for dedicated assessment criteria in a blinded dual-centre read. Ann Oncol. 2011;22(5):1198-1203.
    • (2011) Ann Oncol , vol.22 , Issue.5 , pp. 1198-1203
    • Furth, C.1    Amthauer, H.2    Hautzel, H.3
  • 25
    • 79958067512 scopus 로고    scopus 로고
    • Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: Comparison of International Harmonization Project (IHP), Gallamini and London criteria
    • Le Roux PY, Gastinne T, Le Gouill S, et al. Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria. Eur J Nucl Med Mol Imaging. 2011;38(6):1064-1071.
    • (2011) Eur J Nucl Med Mol Imaging , vol.38 , Issue.6 , pp. 1064-1071
    • Le Roux, P.Y.1    Gastinne, T.2    Le Gouill, S.3
  • 26
    • 79952011010 scopus 로고    scopus 로고
    • Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma
    • Barrington SF, Mackewn JE, Schleyer P, et al. Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma. Ann Oncol. 2011; 22(3):739-745.
    • (2011) Ann Oncol , vol.22 , Issue.3 , pp. 739-745
    • Barrington, S.F.1    Mackewn, J.E.2    Schleyer, P.3
  • 27
    • 84973587732 scopus 로고
    • A coefficient of agreement for nominal scales
    • Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37-46.
    • (1960) Educ Psychol Meas , vol.20 , Issue.1 , pp. 37-46
    • Cohen, J.1
  • 28
    • 84904810169 scopus 로고    scopus 로고
    • Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/ FIL H10 trial
    • Raemaekers JM, André MP, Federico M, et al. Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/ FIL H10 trial. J Clin Oncol. 2014;32(12): 1188-1194.
    • (2014) J Clin Oncol , vol.32 , Issue.12 , pp. 1188-1194
    • Raemaekers, J.M.1    André, M.P.2    Federico, M.3
  • 29
    • 84928492025 scopus 로고    scopus 로고
    • Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma
    • Radford J, Illidge T, Counsell N, et al. Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma. N Engl J Med. 2015; 372(17):1598-1607.
    • (2015) N Engl J Med , vol.372 , Issue.17 , pp. 1598-1607
    • Radford, J.1    Illidge, T.2    Counsell, N.3
  • 31
    • 84871798380 scopus 로고    scopus 로고
    • Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/ computed tomography-staged treatment-naive patients with Hodgkin lymphoma
    • El-Galaly TC, d'Amore F, Mylam KJ, et al. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/ computed tomography-staged treatment-naive patients with Hodgkin lymphoma. J Clin Oncol. 2012;30(36):4508-4514.
    • (2012) J Clin Oncol , vol.30 , Issue.36 , pp. 4508-4514
    • El-Galaly, T.C.1    D'Amore, F.2    Mylam, K.J.3
  • 32
    • 0005161390 scopus 로고    scopus 로고
    • Staging Hodgkin's Disease with 18-FDG PET. Comparison with CT and Surgery
    • Young CS, Young BL, Smith SM. Staging Hodgkin's Disease with 18-FDG PET. Comparison with CT and Surgery. Clin Positron Imaging. 1998;1(3):161-164.
    • (1998) Clin Positron Imaging , vol.1 , Issue.3 , pp. 161-164
    • Young, C.S.1    Young, B.L.2    Smith, S.M.3
  • 33
    • 84925310647 scopus 로고    scopus 로고
    • Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: Fewer cases with stage i disease and more with skeletal involvement
    • El-Galaly TC, Hutchings M, Mylam KJ, et al. Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement. Leuk Lymphoma. 2014;55(10):2349-2355.
    • (2014) Leuk Lymphoma , vol.55 , Issue.10 , pp. 2349-2355
    • El-Galaly, T.C.1    Hutchings, M.2    Mylam, K.J.3
  • 34
    • 84892480590 scopus 로고    scopus 로고
    • When should FDGPET be used in the modern management of lymphoma?
    • Barrington SF, Mikhaeel NG. When should FDGPET be used in the modern management of lymphoma? Br J Haematol. 2014;164(3):315-328.
    • (2014) Br J Haematol , vol.164 , Issue.3 , pp. 315-328
    • Barrington, S.F.1    Mikhaeel, N.G.2
  • 35
    • 84870735307 scopus 로고    scopus 로고
    • Impact of [18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: A prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS
    • Dupuis J, Berriolo-Riedinger A, Julian A, et al. Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS. J Clin Oncol. 2012;30(35):4317-4322.
    • (2012) J Clin Oncol , vol.30 , Issue.35 , pp. 4317-4322
    • Dupuis, J.1    Berriolo-Riedinger, A.2    Julian, A.3
  • 36
    • 84881665184 scopus 로고    scopus 로고
    • An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: Comparison between Deauville criteria and DSUVmax
    • Itti E, Meignan M, Berriolo-Riedinger A, et al. An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and DSUVmax. Eur J Nucl Med Mol Imaging. 2013;40(9):1312-1320.
    • (2013) Eur J Nucl Med Mol Imaging , vol.40 , Issue.9 , pp. 1312-1320
    • Itti, E.1    Meignan, M.2    Berriolo-Riedinger, A.3
  • 37
    • 84896042967 scopus 로고    scopus 로고
    • The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma
    • Oki Y, Chuang H, Chasen B, et al. The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma. Br J Haematol. 2014;165(1):112-116.
    • (2014) Br J Haematol , vol.165 , Issue.1 , pp. 112-116
    • Oki, Y.1    Chuang, H.2    Chasen, B.3
  • 38
    • 84904291330 scopus 로고    scopus 로고
    • Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma
    • Nols N, Mounier N, Bouazza S, et al. Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma. Leuk Lymphoma. 2014;55(4): 773-780.
    • (2014) Leuk Lymphoma , vol.55 , Issue.4 , pp. 773-780
    • Nols, N.1    Mounier, N.2    Bouazza, S.3
  • 39
    • 84857754802 scopus 로고    scopus 로고
    • Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP
    • Pregno P, Chiappella A, Bellò M, et al. Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP. Blood. 2012; 119(9):2066-2073.
    • (2012) Blood , vol.119 , Issue.9 , pp. 2066-2073
    • Pregno, P.1    Chiappella, A.2    Bellò, M.3
  • 40
    • 84922032387 scopus 로고    scopus 로고
    • Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: A pooled analysis of central scan review in three multicentre studies
    • Trotman J, Luminari S, Boussetta S, et al. Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies. Lancet Haematol. 2014;1(1): e17-e27.
    • (2014) Lancet Haematol , vol.1 , Issue.1 , pp. e17-e27
    • Trotman, J.1    Luminari, S.2    Boussetta, S.3
  • 41
    • 84901711760 scopus 로고    scopus 로고
    • The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
    • Gallamini A, Barrington SF, Biggi A, et al. The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale. Haematologica. 2014;99(6):1107-1113.
    • (2014) Haematologica , vol.99 , Issue.6 , pp. 1107-1113
    • Gallamini, A.1    Barrington, S.F.2    Biggi, A.3
  • 42
    • 84911002931 scopus 로고    scopus 로고
    • Chemotherapy only in early-stage Hodgkin lymphoma: More relapses but "same" (or possibly worse) survival-reconsidering the misguided trend to omit radiotherapy
    • Yahalom J. Chemotherapy only in early-stage Hodgkin lymphoma: more relapses but "same" (or possibly worse) survival-reconsidering the misguided trend to omit radiotherapy. Curr Hematol Malig Rep. 2014;9(3):212-216.
    • (2014) Curr Hematol Malig Rep , vol.9 , Issue.3 , pp. 212-216
    • Yahalom, J.1
  • 43
    • 84969276671 scopus 로고    scopus 로고
    • Response-adapted therapy based on interim FDG-PET scans in advanced Hodgkin Lymphoma: First analysis of the safety of de-escalation and efficacy of escalation in the International RATHL study (CRUK/07/033)
    • Johnson PW, Federico M, Fossa A, et al. Response-adapted therapy based on interim FDG-PET scans in advanced Hodgkin Lymphoma: First analysis of the safety of de-escalation and efficacy of escalation in the International RATHL study (CRUK/07/033). Hematol Oncol. 2015;33(suppl S1):100-180.
    • (2015) Hematol Oncol , vol.33 , pp. 100-180
    • Johnson, P.W.1    Federico, M.2    Fossa, A.3
  • 44
    • 84925535468 scopus 로고    scopus 로고
    • FDG PET/CT: EANM procedure guidelines for tumour imaging: Version 2.0
    • Boellaard R, Delgado-Bolton R, Oyen WJ, et al; European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328-354.
    • (2015) Eur J Nucl Med Mol Imaging , vol.42 , Issue.2 , pp. 328-354
    • Boellaard, R.1    Delgado-Bolton, R.2    Oyen, W.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.